First, TLR9 is the recognition receptor for mtDNA, which is highly ex-pressed in the intestine, and TLR9 deficiency protects against colitis, indicating that mtDNA-TLR9 signaling is critical and targetable pathway for IBD treatment [177]. The gene discussed is TLR9; the disease is inflammatory bowel disease.